featured
AAD 2015 Annual Meeting: Dr. Robert Brodell’s Take-Aways
Written by
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
-
Shelling ML, Federman DG, Prodanovich S, Kirsner RS. Psoriasis and vascular disease: an unsolved mystery. Am J Med. 2008;121(5):360-365.
-
Patel RV, Shelling ML, Prodanovich S, et al. Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature. J Gen Intern Med. 2011;26(9):1036-1049.
- Shelling ML, Kirsner RS. Lack of appropriate screening for the metabolic syndrome in patients with psoriasis risks underrecognition and undertreatment of important comorbidities: comment on "Prevalence of the metabolic syndrome in psoriasis". Arch Dermatol. 2011;147(4):424-425.
- Shelling ML, Kirsner RS. Failure to counsel patients with psoriasis to decrease alcohol consumption (and smoking). Arch Dermatol. 2010;146(12):1370.
-
Gist DL, Bhushan R, Hamarstrom E, et al. Impact of a Performance Improvement CME activity on the care and treatment of patients with psoriasis.
Disclosure statements are available on the authors' profiles: